Tomasz Zdrojewski
Overview
Explore the profile of Tomasz Zdrojewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
217
Citations
1669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Berger C, Hammer H, Costa M, Lowiec P, Yagensky A, Scutelnic A, et al.
Eur Stroke J
. 2024 May;
9(4):1043-1052.
PMID: 38745422
Introduction: The differences in vascular risk factors' and stroke burden across Europe are notable, however there is limited understanding of the influence of socioeconomic environment on the quality of secondary...
12.
Sulicka-Grodzicka J, Wizner B, Zdrojewski T, Mossakowska M, Puzianowska-Kuznicka M, Chudek J, et al.
Geroscience
. 2024 May;
46(5):4603-4614.
PMID: 38720047
Emerging evidence indicates an association between blood pressure and inflammation, yet this relationship remains unclear in older adults, despite the elevated prevalence of hypertension. We investigated the association between blood...
13.
Springer J, Pejska M, Homenda W, Zdrojewski T, Danilowicz-Szymanowicz L, Kozlowski D
Adv Med Sci
. 2024 Apr;
69(2):248-255.
PMID: 38649031
Purpose: Little is known about the effectiveness of pharmacological cardioversion (PCV) with antazoline in comparison to flecainide. The aim of this study was to compare the effectiveness of antazoline in...
14.
Puch-Walczak A, Kunicka K, Jagiello K, Puzio E, Jankowska H, Hoffman P, et al.
Kardiol Pol
. 2024 Feb;
82(2):175-182.
PMID: 38374779
Background: Chronic heart failure (CHF) is a major healthcare problem. However, there are no epidemiological studies assessing the prevalence of CHF in the general population with diagnosis based on algorithms...
15.
Kasprzyk P, Undrunas A, Dziadziuszko K, Dziedzic R, Kuziemski K, Szurowska E, et al.
J Cardiovasc Dev Dis
. 2024 Jan;
11(1).
PMID: 38248886
(1) Background: Lung cancer screening (LCS) consists of low-dose computed tomography (LDCT) results to reduce lung cancer-related mortality. The LCS program has a unique opportunity to impact CVD mortality by...
16.
Mitrega K, Sredniawa B, Sokal A, Streb W, Kowalczyk J, Opolski G, et al.
Pol Arch Intern Med
. 2024 Jan;
134(3).
PMID: 38164644
Introduction: Although atrial fibrillation (AF) is a well‑known risk factor for ischemic stroke and hospitalization, its effect on mortality has not been clearly established. Objectives: We aimed to assess whether...
17.
Piwonska A, Piwonski J, Cicha-Mikolajczyk A, Kozela M, Pajak A, Smigielski W, et al.
Kardiol Pol
. 2023 Nov;
81(12):1237-1246.
PMID: 37997823
Background: Psychosocial risk factors are important determinants of cardiovascular diseases (CVDs): people involved in positive relationships live longer than those with low social support (SS). Aims: Our study aimed to...
18.
Gumprecht J, Lip G, Sokal A, Sredniawa B, Stokwiszewski J, Zdrojewski T, et al.
Sci Rep
. 2023 Oct;
13(1):17252.
PMID: 37828071
Diabetes mellitus (DM) is a well-known risk factor for atrial fibrillation (AF), but the mechanism(s) by which DM affects AF prevalence remains unclear. This study aims to evaluate the impact...
19.
Kupisz-Urbanska M, Jankowski P, Topor-Madry R, Chudzik M, Gasior M, Gil R, et al.
Kardiol Pol
. 2023 Jul;
81(10):1015-1017.
PMID: 37448218
No abstract available.
20.
Solnica B, Sniderman A, Wyszomirski A, Rutkowski M, Chlebus K, Bandosz P, et al.
Int J Cardiol
. 2023 Jul;
390:131150.
PMID: 37429441
Background: The study compared the distribution of serum LDL-C, non-HDL-C, and apolipoprotein B (apoB) among participants of the NATPOL 2011 survey and analysed concordance/discordance of results in the context of...